ANC 0 3 0 3 B-clinical_variable
≥ 4 5 4 5 O
1.5 6 9 6 9 B-lower_bound
x 10 11 10 11 I-lower_bound
109 12 15 12 15 I-lower_bound
/ 15 16 15 16 I-lower_bound
L 16 17 16 17 I-lower_bound

AST 0 3 18 21 B-clinical_variable
/ 3 4 21 22 I-clinical_variable
ALT 4 7 22 25 I-clinical_variable
≤ 8 9 26 27 O
3 10 11 28 29 B-upper_bound
x 12 13 30 31 I-upper_bound
ULN 14 17 32 35 I-upper_bound

Active 0 6 36 42 O
clinically 7 17 43 53 O
serious 18 25 54 61 O
infections 26 36 62 72 B-clinical_variable
( 37 38 73 74 O
> 38 39 74 75 O
grade 40 45 76 81 B-lower_bound
2 46 47 82 83 I-lower_bound
) 47 48 83 84 O

Active 0 6 85 91 B-chronic_disease
hepatitis 7 16 92 101 I-chronic_disease
B 17 18 102 103 I-chronic_disease
, 18 19 103 104 O
unless 20 26 105 111 O
patient 27 34 112 119 O
has 35 38 120 123 O
been 39 43 124 128 O
on 44 46 129 131 O
antiviral 47 56 132 141 B-treatment
agents 57 63 142 148 I-treatment
for 64 67 149 152 O
at 68 70 153 155 O
least 71 76 156 161 O
2 77 78 162 163 B-lower_bound
months 79 85 164 170 I-lower_bound
( 86 87 171 172 O
baseline 87 95 172 180 O
testing 96 103 181 188 O
not 104 107 189 192 O
required 108 116 193 201 O
) 116 117 201 202 O

Any 0 3 203 206 O
cancer 4 10 207 213 B-cancer
curatively 11 21 214 224 O
treated 22 29 225 232 O
> 30 31 233 234 O
3 31 32 234 235 B-lower_bound
years 33 38 236 241 I-lower_bound
prior 39 44 242 247 I-lower_bound
to 45 47 248 250 O
entry 48 53 251 256 O
with 54 58 257 261 O
no 59 61 262 264 O
clinical 62 70 265 273 O
evidence 71 79 274 282 O
of 80 82 283 285 O
recurrence 83 93 286 296 O

Baseline 0 8 297 305 B-clinical_variable
peripheral 9 19 306 316 I-clinical_variable
neuropathy 20 30 317 327 I-clinical_variable
/ 30 31 327 328 O
paresthesia 31 42 328 339 B-clinical_variable
grade 43 48 340 345 O
≥ 49 50 346 347 O
1 51 52 348 349 B-lower_bound

Creatinine 0 10 350 360 B-clinical_variable
≤ 11 12 361 362 O
1.5 13 16 363 366 B-upper_bound
x 17 18 367 368 I-upper_bound
ULN 19 22 369 372 I-upper_bound
, 22 23 372 373 O
or 24 26 374 376 O
creatinine 27 37 377 387 B-clinical_variable
clearance 38 47 388 397 I-clinical_variable
≥ 48 49 398 399 O
50 50 52 400 402 B-lower_bound
mL 53 55 403 405 I-lower_bound
/ 55 56 405 406 I-lower_bound
min 56 59 406 409 I-lower_bound
( 60 61 410 411 O
estimated 61 70 411 420 O
by 71 73 421 423 O
Cockcroft 74 83 424 433 O
- 83 84 433 434 O
Gault 84 89 434 439 O
or 90 92 440 442 O
measured 93 101 443 451 O
) 101 102 451 452 O

ECOG 0 4 453 457 B-clinical_variable
performance 5 16 458 469 I-clinical_variable
status 17 23 470 476 I-clinical_variable
of 24 26 477 479 O
0 27 28 480 481 B-lower_bound
or 29 31 482 484 O
1 32 33 485 486 B-upper_bound

Has 0 3 487 490 O
not 4 7 491 494 O
been 8 12 495 499 O
naturally 13 22 500 509 O
postmenopausal 23 37 510 524 O
for 38 41 525 528 O
at 42 44 529 531 O
least 45 50 532 537 O
24 51 53 538 540 B-lower_bound
consecutive 54 65 541 552 I-lower_bound
months 66 72 553 559 I-lower_bound
( 73 74 560 561 O
i.e. 74 78 561 565 O
, 78 79 565 566 O
has 80 83 567 570 O
had 84 87 571 574 O
menses 88 94 575 581 O
at 95 97 582 584 O
any 98 101 585 588 O
time 102 106 589 593 O
in 107 109 594 596 O
the 110 113 597 600 O
preceding 114 123 601 610 O
12 124 126 611 613 B-upper_bound
consecutive 127 138 614 625 I-upper_bound
months 139 145 626 632 I-upper_bound
) 145 146 632 633 O

Has 0 3 634 637 O
not 4 7 638 641 O
undergone 8 17 642 651 O
a 18 19 652 653 O
hysterectomy 20 32 654 666 B-treatment
or 33 35 667 669 O
bilateral 36 45 670 679 B-treatment
oophorectomy 46 58 680 692 I-treatment

Hemoglobin 0 10 693 703 B-clinical_variable
≥ 11 12 704 705 O
9 13 14 706 707 B-lower_bound
g 15 16 708 709 I-lower_bound
/ 16 17 709 710 I-lower_bound
dL 17 19 710 712 I-lower_bound
( 20 21 713 714 O
transfusions 21 33 714 726 B-treatment
are 34 37 727 730 O
acceptable 38 48 731 741 O
) 48 49 741 742 O

Histologically 0 14 743 757 O
confirmed 15 24 758 767 O
adenocarcinoma 25 39 768 782 B-cancer
of 40 42 783 785 O
the 43 46 786 789 O
pancreas 47 55 790 798 O
that 56 60 799 803 O
has 61 64 804 807 O
been 65 69 808 812 O
documented 70 80 813 823 O
to 81 83 824 826 O
be 84 86 827 829 O
resectable 87 97 830 840 O
by 98 100 841 843 O
standardized 101 113 844 856 O
radiographic 114 126 857 869 O
criteria 127 135 870 878 O
by 136 138 879 881 O
a 139 140 882 883 O
pancreatic 141 151 884 894 O
surgeon 152 159 895 902 O

History 0 7 903 910 O
of 8 10 911 913 O
or 11 13 914 916 O
suspected 14 23 917 926 O
Gilbert 24 31 927 934 B-chronic_disease
's 31 33 934 936 I-chronic_disease
Disease 34 41 937 944 I-chronic_disease
( 42 43 945 946 O
testing 43 50 946 953 O
not 51 54 954 957 O
required 55 63 958 966 O
if 64 66 967 969 O
presence 67 75 970 978 O
is 76 78 979 981 O
not 79 82 982 985 O
suspected 83 92 986 995 O
) 92 93 995 996 O

Hypersensitivity 0 16 997 1013 O
to 17 19 1014 1016 O
5FU 20 23 1017 1020 B-allergy_name
, 23 24 1020 1021 O
oxaliplatin 25 36 1022 1033 B-allergy_name
( 37 38 1034 1035 O
or 38 40 1035 1037 O
other 41 46 1038 1043 O
platinum 47 55 1044 1052 B-allergy_name
agents 56 62 1053 1059 I-allergy_name
) 62 63 1059 1060 O
, 63 64 1060 1061 O
irinotecan 65 75 1062 1072 B-allergy_name
( 76 77 1073 1074 O
or 77 79 1074 1076 O
to 80 82 1077 1079 O
their 83 88 1080 1085 O
excipients 89 99 1086 1096 B-allergy_name
) 99 100 1096 1097 O

Inability 0 9 1098 1107 O
to 10 12 1108 1110 O
receive 13 20 1111 1118 O
a 21 22 1119 1120 O
port 23 27 1121 1125 O
or 28 30 1126 1128 O
PICC 31 35 1129 1133 B-treatment
line 36 40 1134 1138 I-treatment

Major 0 5 1139 1144 B-treatment
surgery 6 13 1145 1152 I-treatment
or 14 16 1153 1155 O
significant 17 28 1156 1167 O
traumatic 29 38 1168 1177 B-chronic_disease
injury 39 45 1178 1184 I-chronic_disease
within 46 52 1185 1191 O
8 53 54 1192 1193 B-upper_bound
weeks 55 60 1194 1199 I-upper_bound
of 61 63 1200 1202 O
first 64 69 1203 1208 O
study 70 75 1209 1214 O
drug 76 80 1215 1219 O
. 80 81 1219 1220 O
A 82 83 1221 1222 O
core 84 88 1223 1227 B-treatment
pancreatic 89 99 1228 1238 I-treatment
or 100 102 1239 1241 O
liver 103 108 1242 1247 B-treatment
biopsy 109 115 1248 1254 I-treatment
does 116 120 1255 1259 O
not 121 124 1260 1263 O
preclude 125 133 1264 1272 O
the 134 137 1273 1276 O
patient 138 145 1277 1284 O
from 146 150 1285 1289 O
the 151 154 1290 1293 O
study 155 160 1294 1299 O

Other 0 5 1300 1305 O
malignancies 6 18 1306 1318 B-cancer
within 19 25 1319 1325 O
the 26 29 1326 1329 O
past 30 34 1330 1334 B-upper_bound
3 35 36 1335 1336 I-upper_bound
years 37 42 1337 1342 I-upper_bound

Participation 0 13 1343 1356 O
in 14 16 1357 1359 O
any 17 20 1360 1363 B-treatment
investigational 21 36 1364 1379 I-treatment
drug 37 41 1380 1384 I-treatment
study 42 47 1385 1390 I-treatment
within 48 54 1391 1397 O
4 55 56 1398 1399 B-upper_bound
weeks 57 62 1400 1405 I-upper_bound
preceding 63 72 1406 1415 O
the 73 76 1416 1419 O
start 77 82 1420 1425 O
of 83 85 1426 1428 O
study 86 91 1429 1434 O
treatment 92 101 1435 1444 B-treatment

Patients 0 8 1445 1453 O
are 9 12 1454 1457 O
not 13 16 1458 1461 O
permitted 17 26 1462 1471 O
to 27 29 1472 1474 O
participate 30 41 1475 1486 O
in 42 44 1487 1489 O
another 45 52 1490 1497 B-treatment
investigational 53 68 1498 1513 I-treatment
drug 69 73 1514 1518 I-treatment
study 74 79 1519 1524 I-treatment
while 80 85 1525 1530 O
being 86 91 1531 1536 O
treated 92 99 1537 1544 O
on 100 102 1545 1547 O
this 103 107 1548 1552 O
protocol 108 116 1553 1561 O

Patients 0 8 1562 1570 O
must 9 13 1571 1575 O
to 14 16 1576 1578 O
have 17 21 1579 1583 O
tumor 22 27 1584 1589 B-cancer
tissue 28 34 1590 1596 O
collected 35 44 1597 1606 O
prior 45 50 1607 1612 O
to 51 53 1613 1615 O
enrolling 54 63 1616 1625 O
on 64 66 1626 1628 O
this 67 71 1629 1633 O
trial 72 77 1634 1639 O

Platelets 0 9 1640 1649 B-clinical_variable
≥ 10 11 1650 1651 O
100 12 15 1652 1655 B-lower_bound
x 16 17 1656 1657 I-lower_bound
109 18 21 1658 1661 I-lower_bound
/ 21 22 1661 1662 I-lower_bound
L 22 23 1662 1663 I-lower_bound

Pregnant 0 8 1664 1672 B-pregnancy

Prior 0 5 1673 1678 B-treatment
therapy 6 13 1679 1686 I-treatment
for 14 17 1687 1690 O
pancreatic 18 28 1691 1701 B-cancer
adenocarcinoma 29 43 1702 1716 I-cancer

Psychological 0 13 1717 1730 B-chronic_disease
, 13 14 1730 1731 O
familial 15 23 1732 1740 B-chronic_disease
, 23 24 1740 1741 O
sociological 25 37 1742 1754 B-chronic_disease
or 38 40 1755 1757 O
geographical 41 53 1758 1770 B-chronic_disease
condition 54 63 1771 1780 I-chronic_disease
potentially 64 75 1781 1792 O
hampering 76 85 1793 1802 O
compliance 86 96 1803 1813 O
with 97 101 1814 1818 O
the 102 105 1819 1822 O
study 106 111 1823 1828 O
protocol 112 120 1829 1837 O
and 121 124 1838 1841 O
follow 125 131 1842 1848 O
- 131 132 1848 1849 O
up 132 134 1849 1851 O
schedule 135 143 1852 1860 O

Total 0 5 1861 1866 B-clinical_variable
bilirubin 6 15 1867 1876 I-clinical_variable
≤ 16 17 1877 1878 O
1.5 18 21 1879 1882 B-upper_bound
x 22 23 1883 1884 I-upper_bound
ULN 24 27 1885 1888 I-upper_bound

Unable 0 6 1889 1895 O
or 7 9 1896 1898 O
unwilling 10 19 1899 1908 O
to 20 22 1909 1911 O
discontinue 23 34 1912 1923 O
use 35 38 1924 1927 O
of 39 41 1928 1930 O
ketoconazole 42 54 1931 1943 B-treatment
or 55 57 1944 1946 O
St 58 60 1947 1949 B-treatment
John 61 65 1950 1954 I-treatment
's 65 67 1954 1956 I-treatment
wort 68 72 1957 1961 I-treatment
. 72 73 1961 1962 O
Use 74 77 1963 1966 O
of 78 80 1967 1969 O
phenytoin 81 90 1970 1979 B-treatment
, 90 91 1979 1980 O
carbamazepine 92 105 1981 1994 B-treatment
, 105 106 1994 1995 O
phenobarbital 107 120 1996 2009 B-treatment
, 120 121 2009 2010 O
rifampin 122 130 2011 2019 B-treatment
and 131 134 2020 2023 O
rifabutin 135 144 2024 2033 B-treatment
is 145 147 2034 2036 O
discouraged 148 159 2037 2048 O
, 159 160 2048 2049 O
but 161 164 2050 2053 O
not 165 168 2054 2057 O
contraindicated 169 184 2058 2073 O

Up 0 2 2074 2076 O
to 3 5 2077 2079 O
10 6 8 2080 2082 B-upper_bound
patients 9 17 2083 2091 O
will 18 22 2092 2096 O
be 23 25 2097 2099 O
accepted 26 34 2100 2108 O
with 35 39 2109 2113 O
no 40 42 2114 2116 O
pre 43 46 2117 2120 B-treatment
- 46 47 2120 2121 I-treatment
treatment 47 56 2121 2130 I-treatment
research 57 65 2131 2139 O
tissue 66 72 2140 2146 O
collection 73 83 2147 2157 O
or 84 86 2158 2160 O
tissue 87 93 2161 2167 O
collection 94 104 2168 2178 O
from 105 109 2179 2183 O
an 110 112 2184 2186 O
outside 113 120 2187 2194 O
institution 121 132 2195 2206 O

WOCBP 0 5 2207 2212 O
and 6 9 2213 2216 O
men 10 13 2217 2220 B-gender
must 14 18 2221 2225 O
agree 19 24 2226 2231 B-contraception_consent
to 25 27 2232 2234 I-contraception_consent
use 28 31 2235 2238 I-contraception_consent
adequate 32 40 2239 2247 I-contraception_consent
contraception 41 54 2248 2261 I-contraception_consent
prior 55 60 2262 2267 O
, 60 61 2267 2268 O
to 62 64 2269 2271 O
study 65 70 2272 2277 O
entry 71 76 2278 2283 O
, 76 77 2283 2284 O
for 78 81 2285 2288 O
the 82 85 2289 2292 O
duration 86 94 2293 2301 O
of 95 97 2302 2304 O
study 98 103 2305 2310 O
participation 104 117 2311 2324 O
, 117 118 2324 2325 O
and 119 122 2326 2329 O
8 123 124 2330 2331 B-upper_bound
weeks 125 130 2332 2337 I-upper_bound
after 131 136 2338 2343 O
the 137 140 2344 2347 O
end 141 144 2348 2351 O
of 145 147 2352 2354 O
treatment 148 157 2355 2364 B-treatment

Women 0 5 2365 2370 B-gender
of 6 8 2371 2373 O
childbearing 9 21 2374 2386 O
potential 22 31 2387 2396 O
definition 32 42 2397 2407 O
( 43 44 2408 2409 O
WOCBP 44 49 2409 2414 O
) 49 50 2414 2415 O
must 51 55 2416 2420 O
have 56 60 2421 2425 O
a 61 62 2426 2427 O
negative 63 71 2428 2436 B-pregnancy
serum 72 77 2437 2442 I-pregnancy
or 78 80 2443 2445 I-pregnancy
urine 81 86 2446 2451 I-pregnancy
pregnancy 87 96 2452 2461 I-pregnancy
test 97 101 2462 2466 O
performed 102 111 2467 2476 O
within 112 118 2477 2483 O
14 119 121 2484 2486 B-upper_bound
days 122 126 2487 2491 I-upper_bound
prior 127 132 2492 2497 I-upper_bound
to 133 135 2498 2500 O
initiation 136 146 2501 2511 O
of 147 149 2512 2514 O
FOLFIRINOX 150 160 2515 2525 B-treatment

adequately 0 10 2526 2536 O
treated 11 18 2537 2544 O
cervical 19 27 2545 2553 B-cancer
or 28 30 2554 2556 O
vulvar 31 37 2557 2563 B-cancer
carcinoma 38 47 2564 2573 I-cancer
in 48 50 2574 2576 I-cancer
situ 51 55 2577 2581 I-cancer
, 55 56 2581 2582 O
treated 57 64 2583 2590 O
basal 65 70 2591 2596 B-cancer
cell 71 75 2597 2601 I-cancer
or 76 78 2602 2604 O
squamous 79 87 2605 2613 B-cancer
carcinoma 88 97 2614 2623 I-cancer
of 98 100 2624 2626 I-cancer
the 101 104 2627 2630 I-cancer
skin 105 109 2631 2635 I-cancer
, 109 110 2635 2636 O
superficial 111 122 2637 2648 B-cancer
bladder 123 130 2649 2656 I-cancer
tumors 131 137 2657 2663 I-cancer
( 138 139 2664 2665 O
Ta 139 141 2665 2667 O
, 141 142 2667 2668 O
Tis 143 146 2669 2672 O
& 147 148 2673 2674 O
T1 149 151 2675 2677 O
) 151 152 2677 2678 O
, 152 153 2678 2679 O
ductal 154 160 2680 2686 B-cancer
carcinoma 161 170 2687 2696 I-cancer
in 171 173 2697 2699 I-cancer
situ 174 178 2700 2704 I-cancer
( 179 180 2705 2706 I-cancer
DCIS 180 184 2706 2710 I-cancer
) 184 185 2710 2711 I-cancer
of 186 188 2712 2714 I-cancer
the 189 192 2715 2718 I-cancer
breast 193 199 2719 2725 I-cancer
and 200 203 2726 2729 O
low 204 207 2730 2733 O
grade 208 213 2734 2739 O
prostate 214 222 2740 2748 B-cancer
cancer 223 229 2749 2755 I-cancer

lactating 0 9 2756 2765 O
women 10 15 2766 2771 B-gender

≥ 0 1 2772 2773 O
18 2 4 2774 2776 B-lower_bound
years 5 10 2777 2782 I-lower_bound
old 11 14 2783 2786 O
at 15 17 2787 2789 O
the 18 21 2790 2793 O
time 22 26 2794 2798 O
of 27 29 2799 2801 O
informed 30 38 2802 2810 O
consent 39 46 2811 2818 O

